A new study into U.S. cancer data finds that checkpoint blockade immunotherapy doubles median overall survival in melanoma patients with brain metastases.
from Featured Health News from Medical News Today https://ift.tt/2KUJ6TW
Home
»
Featured Health News from Medical News Today
»
Health
» Medical News Today: Melanoma: Immunotherapy for brain metastases 'doubles survival'
Subscribe to:
Post Comments (Atom)
Post a Comment